Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2019 2
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
ZMYM2 inhibits NANOG-mediated reprogramming.
Lawrence M, Theunissen TW, Lombard P, Adams DJ, Silva JCR. Lawrence M, et al. Wellcome Open Res. 2019 Jun 6;4:88. doi: 10.12688/wellcomeopenres.15250.1. eCollection 2019. Wellcome Open Res. 2019. PMID: 31363497 Free PMC article.
Using genome editing to engineer universal platelets.
Lawrence M, Mueller A, Ghevaert C. Lawrence M, et al. Emerg Top Life Sci. 2019 May 31;3(3):301-311. doi: 10.1042/ETLS20180153. Emerg Top Life Sci. 2019. PMID: 33523140 Free PMC article.
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.
Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, Shliaha PV, Fidalgo M, Saunders A, Lawrence M, Dietmann S, Das S, Levasseur DN, Li Z, Xu M, Reik W, Silva JC, Wang J. Costa Y, et al. Among authors: lawrence m. Nature. 2013 Mar 21;495(7441):370-4. doi: 10.1038/nature11925. Epub 2013 Feb 10. Nature. 2013. PMID: 23395962 Free PMC article.
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia.
Bennett C, Lawrence M, Guerrero JA, Stritt S, Waller AK, Yan Y, Mifsud RW, Ballester-Beltrán J, Baig A, Mueller A, Mayer L, Warland J, Penkett CJ, Akbari P, Moreau T, Evans AL, Mookerjee S, Hoffman GJ, Saeb-Parsy K, Adams DJ, Couzens AL, Bender M, Erber WN, Nieswandt B, Read RJ, Ghevaert C. Bennett C, et al. Among authors: lawrence m. Blood. 2022 Apr 7;139(14):2227-2239. doi: 10.1182/blood.2021013113. Blood. 2022. PMID: 35051265 Free article.